KRISTA LAND: Open Payments
NPI 1316346299 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 68 payments from 10 companies in 2025. Trend: 2023 $1,325 · 2024 $1,230 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $551 |
| Janssen Biotech, Inc. | 7 | $205 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| Ardelyx, Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Boston Scientific Corporation | 1 | $20 |
Products named: RINVOQ, TREMFYA, LINZESS, XIFAXAN, OCALIVA, CREON, ENTYVIO, IBSRELA.
Industry payments across IN — which companies pay providers there.
